DOD Amyotrophic Lateral Sclerosis, Therapeutic Idea Award
Agency: Dept. of the Army -- USAMRAA
Assistance Listings: 12.420 -- Military Medical Research and Development
Last Updated: April 18, 2025
Description
Summary: The fiscal year 2025 (FY25) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Idea Award (TIA) supports new, innovative, high-risk, high-gain ideas aimed at Amyotrophic Lateral Sclerosis (ALS) drug or therapy discovery. The studies supported by this award mechanism are expected to be hypothesis-driven and generate preliminary data for future avenues of therapeutic investigation.
Distinctive Features: Applications may demonstrate the ability to achieve interpretable results in the absence of preliminary data supporting the hypothesis. While the inclusion of preliminary data is not prohibited, the strength of the application should rely on the approach.
Eligibility
Eligible applicants
Miscellaneous
- Unrestricted
Additional information
Grantor contact information
Description
CDMRP Help Desk
Documents
| File name | Description | Last updated |
|---|---|---|
| A03_HT9425FY25ALSRPTIA.pdf | FY25 ALSRP TIA Program Announcement | Apr 18, 2025 06:03 PM UTC |
Link to additional information
--
Closing: August 27, 2025
Award
$10,800,000
Program Funding
11
Expected awards
$--
Award Floor
$--
Award Ceiling
Funding opportunity number:
HT942525ALSRPTIA
Cost sharing or matching requirement:
Funding instrument type:
Grant
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Science technology and other research and development
Category Explanation:
History
Version:
2
Posted date:
April 18, 2025
Archive date:
September 26, 2025
